SHIFT AI Newsroom · GLOBAL
Semaglutide Shows Promise in Slowing Ageing in Female Mice
Research published in a recent study suggests that late-life semaglutide treatment may slow ageing and extend lifespan in female mice.
A recent study published on Europe PMC found that late-life semaglutide treatment slows ageing and extends lifespan in female mice. The study's findings are promising, but more research is needed to determine if semaglutide has similar effects in humans.
What this means in the UK
While the study's findings are promising, it's essential to note that the research was conducted on mice, and more studies are needed to determine if semaglutide has similar effects in humans. The UK regulatory status and potential NHS access to semaglutide for this purpose are currently unknown.
Known facts
- Late-life semaglutide treatment slows ageing and extends lifespan in female mice.